Skip to search formSkip to main contentSkip to account menu

Estramustine phosphate

Known as: Estramustin Phosphate, Estramustinphosphate, Phosphate, Estramustin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
The safety, toxicity, and immunological response of individualized peptide vaccination or human leukocyte antigen (HLA)‐A24… 
2004
2004
This study was conducted to determine the similarity of response rates and safety produced by weekly paclitaxel with or without… 
Highly Cited
2003
Highly Cited
2003
PURPOSE Prostate cancer is known to be refractory to chemotherapy with only mitoxantrone showing some benefit. Recent clinical… 
Highly Cited
1985
Highly Cited
1985
Estramustine phosphate (0.01 to 0.5 mM), an estradiol mustard derivative used in the therapy of prostatic carcinoma, inhibited… 
Highly Cited
1982
Highly Cited
1982
The [3H]estramustine-binding macromolecule in human prostate was partially characterized using a number of chromatographic… 
1980
1980
Thirty patients with advanced carcinoma of the prostate were treated with estramustine phosphate. All patients were followed up… 
Highly Cited
1979
Highly Cited
1979
The tissue distribution of [3H]estramustine, the dephosphorylated metabolite of estramustine phosphate (Estracyt), in the male… 
Highly Cited
1977
Highly Cited
1977
The Dunning R3327H rat prostatic adenocarcinoma appears to be an appropriate animal model for studying prostatic cancer. This… 
1977
1977
30 patients with oestrogen-escaped carcinoma of the prostate have been treated with estramustine phosphate (Estracyt). 27% showed…